⌘K

INVO Bioscience, Inc. (INVO)

$0.72 4.99% $0.03 Healthcare

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Market cap

$2.81M

CEO

Mr. Steven M. Shum

Full time employees

10.00

Headquarters

Sarasota, FL

IPO Date

Nov 11, 2008

Price-to-earnings (PE) Ratio

1.04

Earnings-per-share (EPS)

$0.69

Cash ratio (TTM)

0.12

Current ratio (TTM)

0.30

Net profit margin (TTM)

-122.80%

PE ratio (TTM)

-0.35

PEG ratio (TTM)

-0.02

Price-to-book ratio (TTM)

1.81

Price-to-sales ratio (TTM)

0.46

Quick ratio (TTM)

0.27

Return on assets (TTM)

-39.29%

Return on equity (TTM)

-1,073.76%

Similar stocks (2)

Enveric Biosciences, Inc.

ENVB

$0.50 1.36% $0.00

Downtrend

Lixte Biotechnology Holdings, Inc.

LIXT

$1.80 -10.00% $-0.20

Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Extended Market Index Fund

VXF

$183.14 2.12% $3.80

Uptrend

Downtrend

Similar stocks (2)

Enveric Biosciences, Inc.

ENVB

$0.50 1.36% $0.00

Downtrend

Lixte Biotechnology Holdings, Inc.

LIXT

$1.80 -10.00% $-0.20

Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Extended Market Index Fund

VXF

$183.14 2.12% $3.80

Uptrend